ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte...

35
ПУБЛИКОВАЛИ СМО у 2009. години

Transcript of ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte...

Page 1: ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte disturbances in a hospital. Pharmacoepidemiol Drug Saf 2009; 18(11):1026-33. IF 2.516 4. Jankovic

ПУБЛИКОВАЛИ СМО

у 2009. години

Page 2: ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte disturbances in a hospital. Pharmacoepidemiol Drug Saf 2009; 18(11):1026-33. IF 2.516 4. Jankovic

Предмет или катедра број радова укупан IF

Генетика 8 29.080

Имунологија 11 26.893

Фармакологија и

Фармација

16 14.668

Хемија 10 14.662

Патолошка физиологија 9 11.442

Физиологија 8 4.782

Интерна медицина 10 3.773

Нуклеарна медицина 2 3.0

Паролошка анатомија 5 2.916

Биохемија 4 1.521

Инфективне болести 2 1.241

Хирургија 3 0.912

Психијатрија 4 0.388

Гинекологија 4 0

Хистологија 3 0

Епидемиологија 2 0

Социјална медицина 2 0

Педијатрија 2 0

Анатомија 1 0

ОРЛ 1 0

Судска медицина 1 0

Page 3: ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte disturbances in a hospital. Pharmacoepidemiol Drug Saf 2009; 18(11):1026-33. IF 2.516 4. Jankovic
Page 4: ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte disturbances in a hospital. Pharmacoepidemiol Drug Saf 2009; 18(11):1026-33. IF 2.516 4. Jankovic

Радови објављени у научним часописима на SCI листи

Page 5: ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte disturbances in a hospital. Pharmacoepidemiol Drug Saf 2009; 18(11):1026-33. IF 2.516 4. Jankovic

ГЕНЕТИКА1. Zhang X, Neganova I, Przyborski S, Yang C, Cooke M, Atkinson SP, Anyfantis G,

Fenyk S, Keith WN, Hoare SF, Hughes O, Strachan T, Stojkovic M, Hinds PW,Armstrong L, Lako M. A role for NANOG in G1 to S transition in human embryonicstem cells through direct binding of CDK6 and CDC25A. J Cell Biol 2009;184(1):67-82. IF 9.120

2. Moreno-Manzano V, Rodríguez-Jiménez FJ, García-Roselló M, Laínez S, Erceg S,Calvo MT, Ronaghi M, Lloret M, Planells-Cases R, S{nchez-Puelles JM, Stojkovic M.Activated spinal cord ependymal stem cells rescue neurological function. Stem Cells2009;27(3):733-43. IF 7.741

3. Erceg S, Ronaghi M, Stojković M. Human embryonic stem cell differentiationtoward regional specific neural precursors. Stem Cells 2009;27(1):78-87. IF 7.741

4. Cervera RP, Stojkovic M. Developments and Challenges in Human Embryonic StemCell Research in Spain. Stem Cell Rev Rep in press IF 4.2

5. Nayernia K, Lee JH, Lako M, Armstrong L, Herbert M, Li M, Engel W, Elliott D,Stojkovic M, Parrington J, Murdoch A, Strachan T, Zhang X. RETRACTION - InVitro Derivation of Human Sperm from Embryonic Stem Cells. Stem Cells Dev inpress IF 3.273

6. Cervera RP, Martí-Gutiérrez N, Escorihuela E, Moreno R, Stojkovic M. TrichostatinA affects histone acetylation and gene expression in porcine somatic cell nucleustransfer embryos. Theriogenology 2009;72(8):1097-10. IF 2.041

7. Cervera R, Silvestre M, Martí N, García-Mengual E, Moreno R, Stojkovic M. Effectsof Different Oocyte Activation Procedures on Development and Gene Expression ofPorcine Pre-Implantation Embryos. Reprod Domest Anim in press IF 1.526

8. Radosavljevic G, Ljujic B, Jovanovic I, Srzentic Z, Pavlovic S, Zdravkovic N,Milovanovic M, Bankovic D, Knezevic M, Acimovic LJ, Arsenijevic N. Interleukin-17 may be a valuable serum tumour marker in patients with colorectal carcinoma.Neoplasma in press IF 1.179

Page 6: ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte disturbances in a hospital. Pharmacoepidemiol Drug Saf 2009; 18(11):1026-33. IF 2.516 4. Jankovic

ИМУНОЛОГИЈА1. Jiang HR, Al Rasebi Z, Mensah-Brown E, Shahin A, Xu D, Goodyear CS, Fukada SY,

Liu FT, Liew FY, Lukic ML. Galectin-3 deficiency reduces the severity ofexperimental autoimmune encephalomyelitis. J Immunol 2009;182(2):1167-73. IF 6.000

2. Ge L, Baskic D, Basse P, Vujanovic L, Unlu S, Yoneyama T, Vujanovic A, Han J,Bankovic D, Szczepanski MJ, Hunt JL, Herberman RB, Gollin SM, Ferris RL,Whiteside TL, Myers EN, Vujanovic NL. Sheddase activity of tumor necrosis factor-alpha converting enzyme is increased and prognostically valuable in head and neckcancer. Cancer Epidemiol Biomarkers Prev 2009; 18(11):2913-22 IF 4.77

3. Mensah-Brown EP, Al Rabesi Z, Shahin A, Al Shamsi M, Arsenijevic N, Hsu DK, LiuFT. and Lukic ML. Targeted disruption of the galectin-3 gene results in decreasedsusceptibility to multiple low dose streptozotocin-induced. Clin Immunol2009;130(1):83-8. IF 3.606

4. Lukic ML, Arsenijevic N, Mitchison NA. Inflammation at the interface of Innate andAcquired Immunity. Mol Immunol 2009;47(1):1-2. IF 3.555

5. Zdravkovic N, Shahin A, Arsenijevic N, Lukic ML and Eric PK Mensah- Brown.Regulatory T cells and ST2 signaling control diabetes induction with multiple lowdoses of streptozotocin. Molecular Immunology 2009; 47(1):28-36. IF 3.555

6. Volarevic V, Al-Qahtani A, Arsenijevic N, Pajovic S, Lukic ML. Interleukin-1receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells asmodulators of diabetogenesis. Autoimmunity in press IF 2.525

7. Djurdjevic P, Zelen I, Ristic P, Baskic D, Popovic S, Arsenijevic N. Role ofdecreased production of Interleukin-10 and Interferon Gamma in spontaneousapoptosis of B-Chronic Lymphocytic Leukemia Lymphocytes in vitro. Archives ofMedical Research 2009; 40:357-63. IF 1.703

8. Radosavljevic G, Ljujic B, Jovanovic I, Srzentic Z, Pavlovic S, Zdravkovic N,Milovanovic M, Bankovic D, Knezevic M, Acimovic LJ, Arsenijevic N. Interleukin-17 may be a valuable serum tumour marker in patients with colorectal carcinoma.Neoplasma in press IF 1.179

Page 7: ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte disturbances in a hospital. Pharmacoepidemiol Drug Saf 2009; 18(11):1026-33. IF 2.516 4. Jankovic

ИМУНОЛОГИЈА

9. Zelen I, Djurdjevic P, Popovic S, Stojanovic M, Jakovljevic V, Radivojevic S,Baskic D, Arsenijevic N. Antioxidant enzymes activities and plasma levels ofoxidative stress markers in B-chronic lymphocyte leukemia patients. J BUON inpress

10. Djurdjevic P, Zelen I, Ristic P, Jovanovic I, Jakovljevic V, Baskic D, PopovicS, Arsenijevic N. Oxidative stress accelerate spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes. J BUON 2009;14(2):281-7.

11. Petrović M, Ilić N, Baskić D. Značaj neuroendokrinih markera u odgovoru naterapiju i preživljavanje kod pacijenata sa odmaklim nemikrocelularnimkarcinomom pluća. Srp Arh Celok Lek in press

Page 8: ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte disturbances in a hospital. Pharmacoepidemiol Drug Saf 2009; 18(11):1026-33. IF 2.516 4. Jankovic

ФАРМАКОЛОГИЈА И ФАРМАЦИЈА

1. Jankovic SM, Jankovic SV, Lukic G, Radonjic V, Cupara S, Stefanovic S.Contractile effects of endothelins on isolated ampullar segment of human oviductin luteal phase of menstrual cycle. Pharmacol Res 2009; 59(1):69-73. IF 3.287.

2. Matovic DM, Jankovic MS, Jeremic M, Tasic Z, Vlajkovic M. Unexpected effect offurosemide on radioiodine urinary excretion in patients with differentiatedthyroid carcinomas treated with Iodine 131. Thyroid 2009; 19(8):843-48. IF 3.000

3. Zornić N, Radojević DJ, Janković S, Djurić D, Varjačić M, Simić VD, MilovanovićDR. Monitoring of drug- associated electrolyte disturbances in a hospital.Pharmacoepidemiol Drug Saf 2009; 18(11):1026-33. IF 2.516

4. Jankovic SM, Jankovic SV, Stojadinovic D, Stojadinovic M, Kostovic V,Novakovic M, Markovic V. Effects of exogenous glutamate and kainate on electricfield-stimulated contractions of isolated human ureter. Urology 2009; 73(5):1136-9.IF 2.242

5. Jankovic SM, Aleksic J, Rakovic S, Aleksic A, Stevanovic I, Stefanovic-StoimenovN, Radosavljevic M, Kostic M, Tesic D, Petrovic B. Nonsteroidal antiinflammatorydrugs and risk of gastrointestinal bleeding among patients on hemodialysis. JNephrol 2009;22(4):502-7. IF 1.211

6. Jankovic SM, Jovanovic D, Milovanovic JR. Pharmacokinetic modeling ofcarbamazepine based on clinical data from Serbian epileptic patients. MethodsFind Exp Clin Pharmacol 2008; 30(9): 707-13. IF 1.00

7. Stojadinović MM, Mićić SR, Milovanović DR, Janković SM. Risk factors fortreatment failure in renal suppurative infections. Int Urol Nephrol 2009; 41(2): 319-25. IF 0.912

8. Jankovic SM, Kostic M, Radosavljevic M, Jovanovic S. Costs of RheumatoidArthritis in a Balkan Country (Serbia). E Eur Polit Soc 2009; 23(1):135-8. IF 0.500

Page 9: ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte disturbances in a hospital. Pharmacoepidemiol Drug Saf 2009; 18(11):1026-33. IF 2.516 4. Jankovic

ФАРМАКОЛОГИЈА И ФАРМАЦИЈА

9. Ravanic DB, Pantovic MM, Milovanovic DR, Djukic-Dejanovic SM, Janjic V,Ignjatovic DR, Jovic SD, Jurisic V, Jevtovic I. Long-term efficacy ofelectroconvulsive therapy combined with different antipsichotic drugs inpreviously resistant shizophrenia. Psychiatr Danub 2009; 21(2): 179-86.

10. Matović M, Janković S, Jeremić M, Novaković M, Milošev M, Vlajković M. Effectof furosemide on radioiodine-131 retention in mice thyroid gland. Hell J NuclMed 2009; 12(2):129-131.

11. Jankovic SM, Kostic M, Radosavljevic M, Tesic D, Stefanovic-Stoimenov N,Stevanovic I, Rakovic S, Aleksic J, Folic M, Aleksic A, Mihajlovic I, Biorac N,Borlja J, Vuckovic R. Cost-effectivness of four immunomodulatory therapies forrelapsing-remitting multiple sclerosis: a Markov model based on data from aBalkan country in socio-economic transition. Vojnosanit Pregl 2009;66(7):556-62

12. Biorac N, Jakovljevic M, Stefanovic D, Perovic S, Jankovic S. Procena troškovalečenja diabetes mellitus-a tip 2 u Republici Srbiji. Vojnosanit Pregl 2009; 66(4):271-6.

13. Perović S, Janković S. Renal transplantation vs hemodialysis: cost-effectivenessanalysis. Vojnosanit Pregl 2009; 66(8):639-44.

14. Trifunović VS, Gvozdenović BS, Jovanovic D, Vucinić V, Djurić D, Zunić M.Association between tobacco smoking and pulmonary tuberculosis. VojnosanitPregl 2009; 66(10):797-801.

15. Cupara SM, Janković SM. Significance of herbal drugs legislation for theirrational use. Vojnosanit Pregl. 2009; 66(1):53-6.

16. Jakovljevic M, Jozef M, Vovk T, Jankovic S, Grabnar I. Current clinical Evidenceon topiramate pharmacokinetics. Srp Arh Celok Lek 2009; 137(7-8):444-8.

Page 10: ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte disturbances in a hospital. Pharmacoepidemiol Drug Saf 2009; 18(11):1026-33. IF 2.516 4. Jankovic

ХЕМИЈА1. Ivan Damljanović, Mirjana Vukićević, Dragan Manojlović, Neso Sojic, Olivier

Buriez and Rastko D. Vukićević, Electrochemical Bromination of Peracetylated D-Glucal: Effect of DMSO on Chemoselectivity, Electrochimica Acta 55 (2010) 965–969. IF3.078

2. Damljanović I, Vukićević M, Radulović N, Palić R, Ellmerer E, Ratković Z,Joksović MD, Vukićević RD. Synthesis and antimicrobial activity of some newpyrazole derivatives containing a ferrocene unit. Bioorg Med Chem Lett2009;19(4):1093-6. IF 2.531

3. Srećko Trifunović, Dejana Dimitrijević, Gordana Vasić, Niko Radulović, MirjanaVukićević, Frank W. Heinemann, and Rastko D. Vukićević, “New SimpleSynthesis of N-Substituted 1,3-Oxazinan-2-ones”, Accepted for publication inSynthesis 2010. IF 2.470

4. Damljanović, M. Čolović, M. Vukićević, D. Manojlović, N. Radulović, K. Wurst, G.Laus, Z. Ratković, M. Joksović and R. D. Vukićević, ”Synthesis, spectralcharacterization and electrochemical properties of 1H-3-(o-, m- and p-ferrocenylphenyl)-1-phenylpyrazole-4-carboxaldehydes” Journal of OrganometallicChemistry 694 (2009) 1575–1580. IF 1.866

5. Marković ZS, Manojlović NT. DFT study on the reactivity of OH groups inemodin: structural and electronic features of emodin radicals. Monatshefte furChemie 2009; 140:1311–8. IF 1.426

6. Bugracic ZD, Soldatovic T, Canovic P. Nikolic R, Jelic R. Equilibrium and 1HNMR kinetic study of the reactions of dichlorido [S-metihyl-L-cisteine (N,S)]platinum (II) complex with some relevant biomolecules. Journal of SolutionChemistry 2009; 38:57-71. IF 1.241

7. Novokmet S, Jakovljevic VLj, Jankovic S, Davidovic G, Andjelkovic N,Milanovic Z, Djuric DM. Human platelets perfusion through isolated guinea-pigheart: the efects on coronary flow and oxidative stress markers. Gen PhysiolBiophys 2009; 28: 98-104. IF 0.771

Page 11: ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte disturbances in a hospital. Pharmacoepidemiol Drug Saf 2009; 18(11):1026-33. IF 2.516 4. Jankovic

ХЕМИЈА

8. Manojlović N. Antimicrobial activity of extracts and various fractions ofchloroform extract from the lichen Laurera benguelensis. Journal of Biologicalresearch in press IF 0.500

9. Manojlović N, Marković Z, Gritsanapan W, Boonpragob K. High-performance liquid chromatographic analysis of anthraquinone compoundsin the Laurera benguelensis. Russian journal of physical chemistry A 2009;83(9):1554-7. IF 0.477

10. Ivan Damljanović, Klaus Wurstll, Gerhard Lausll, Milan Joksović, ZoranRatković, Mirjana Vukićević and Rastko D. Vukićević, ”Crystal structure of3-ferrocenyl-1-phenylpyrazole-4-carbaldehyde-3-pyridinylmethytimine,Fe(C5H5)( C21H17N4), Z. Kristallogr NCS 224 (2009) 313-314. IF 0.302

Page 12: ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte disturbances in a hospital. Pharmacoepidemiol Drug Saf 2009; 18(11):1026-33. IF 2.516 4. Jankovic

ПАТОЛОШКА ФИЗИОЛОГИЈА

1. Konjević G, Mirjacić Martinović K, Vuletić A, Jurisić V, Spuzić I. Distribution of severalactivating and inhibitory receptors on CD3-CD16+ NK cells and their correlation with NKcell function in healthy individuals. J Membr Biol 2009; 230(3):113-23. IF 2.320

2. Inic-Kanada A, Stojanovic M, Zivkovic I, Kosec D, Micic M, Petrusic V, Zivancevic-Simonovic S, Dimitrijevic L. Murine monoclonal antibody 26 raised against tetanustoxoid cross-reacts with beta2-glycoprotein I: its characteristics and role in molecularmimicry. Am J Reprod Immunol 2009; 61(1):39-51. IF 2.172

3. Colovic N, Jurisic V, Terzic T, Atkinson HD, Colovic M. Immunochemotherapy for Bcl-2and MUM-negative aggressive primary cutaneous B-cell non-Hodgkin's lymphoma. ArchDermatol Res 2009; 301(9):689-92. IF 1.927

4. Konjević G, Mirjacić Martinović K, Jurisić V, Babović N, Spuzić I. Biomarkers ofsuppressed natural killer (NK) cell function in metastatic melanoma: decreased NKG2Dand increased CD158a receptors on CD3-CD16+ NK cells. Biomarkers 2009;14(4):258-70.IF 1.728

5. Colović N, Peruničić M, Jurišić V, Colović M. Specific skin lesions in hairy cell leukemiaat presentation: case report and review of literature. Med Oncol in press IF 1.134

6. Stanojević M, Savin S, Cvejić D, Đukić A, Živančević-Simonović S. Correlation ofthyroglobulin concentrations measured by radioimmunoassay and immunometric assayand the influence of thyroglobulin antibody. J Immunoassay Immunochem 2009, 30:197-207. IF 0.825

7. Stanojević M, Savin S, Cvejić D, Djukić A, Jeremić M. and Živancević-Simonović S.Comparison of the influence of thyroglobulin antibodies on serum thyroglobulin valuesfrom two different immunoassays in post surgical differentiated thyroid carcinomapatients. Journal of Clinical Laboratory Analysis 2009; 23(5):341-6 IF 0.696

8. Jurisić V, Pavlović S, Colović N, Djordjevic V, Bunjevacki V, Janković G, Colović M.Single institute study of FLT3 mutation in acute myeloid leukemia with near tetraploidyin Serbia. J Genet 2009;88(2):149-52. IF 0.640

9. Ravanic DB, Pantovic MM, Milovanovic DR, Djukic-Dejanovic SM, Janjic V, IgnjatovicDR, Jovic SD, Jurisic V, Jevtovic I. Long-term efficacy of electroconvulsive therapycombined with different antipsichotic drugs in previously resistant shizophrenia.Psychiatr Danub 2009; 21(2): 179-86.

Page 13: ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte disturbances in a hospital. Pharmacoepidemiol Drug Saf 2009; 18(11):1026-33. IF 2.516 4. Jankovic

ФИЗИОЛОГИЈА1. Filipovic N, Cvetkovic A, Isailovic V, Matovic Z, Rosic M, Kojic M. Computer

simulation of flow and mixing at the duodenal stump after gastric resection.World J Gastroenterol 2009 28; 15(16):1990-8. IF 2.081

2. Novokmet S, Jakovljevic VLj, Jankovic S, Davidovic G, Andjelkovic N,Milanovic Z, Djuric DM. Human platelets perfusion through isolated guinea-pigheart: the efects on coronary flow and oxidative stress markers. Gen PhysiolBiophys 2009; 28: 98-104. IF 0.771

3. Pantovic S, Rosic G, Obradovic Z, Rankovic G, Stojiljkovic N. and Rosic M.Dynamic response of blood vessel in acute renal failure. Gen Physiol Biophys2009; 28: 87-92. IF 0.771

4. Obradovic Z, Pantovic S, Rosic G, Selakovic Z. and Rosic M. The newexperimental model for behavioral investigations in animal studies. Gen PhysiolBiophys 2009; 28: 77-86. IF 0.771

5. Ravanic DB, Djukic-Dejanovic SM, Janjic V, Jovic SD, Milovanovic DR,Jakovljevic V, Pantovic V, Ravanic B, Pantovic M. and Pantovic MM.Effectiveness of clozapine, haloperidol and chlorpromazine in schizofreniaduring a five-year period. Arquivos De Neuro-psiquiatria 2009; 67(2):195-202. IF0.388

6. Zelen I, Djurdjevic P, Popovic S, Stojanovic M, Jakovljevic V, Radivojevic S,Baskic D, Arsenijevic N. Antioxidant enzymes activities and plasma levels ofoxidative stress markers in B-chronic lymphocyte leukemia patients. J BUON inpress

7. Djurdjevic P, Zelen I, Ristic P, Jovanovic I, Jakovljevic V, Baskic D, Popovic S,Arsenijevic N. Oxidative stress accelerate spontaneous apoptosis of B-chroniclymphocytic leukemia lymphocytes. J BUON 2009;14(2):281-7.

8. Tomic-Lucic A, Pantovic S, Rosic G, Obradovic Z, Rosic M. Histamine indexand clinical expression of theumathoid arthritis activity. Vojnosanit Pregl in press

Page 14: ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte disturbances in a hospital. Pharmacoepidemiol Drug Saf 2009; 18(11):1026-33. IF 2.516 4. Jankovic

ИНТЕРНА МЕДИЦИНА1. Djurdjevic P, Zelen I, Ristic P, Baskic D, Popovic S, Arsenijevic N. Role of decreased

production of Interleukin-10 and Interferon Gamma in spontaneous apoptosis of B-Chronic Lymphocytic Leukemia Lymphocytes in vitro. Archives of Medical Research2009; 40:357-63. IF 1.703

2. Petrović D, Obrenović R, Stojimirović B. Risk Factors for Aortic Valve Calcification inPatients on Regular Hemodialysis. Int J Artif Organs 2009; 32(3): 173-9. IF 1.299

3. Novokmet S, Jakovljevic VLj, Jankovic S, Davidovic G, Andjelkovic N, Milanovic Z,Djuric DM. Human platelets perfusion through isolated guinea-pig heart: the efects oncoronary flow and oxidative stress markers. Gen Physiol Biophys 2009; 28: 98-104. IF0.771

4. Zelen I, Djurdjevic P, Popovic S, Stojanovic M, Jakovljevic V, Radivojevic S, Baskic D,Arsenijevic N. Antioxidant enzymes activities and plasma levels of oxidative stressmarkers in B-chronic lymphocyte leukemia patients. J BUON in press

5. Djurdjevic P, Zelen I, Ristic P, Jovanovic I, Jakovljevic V, Baskic D, Popovic S,Arsenijevic N. Oxidative stress accelerate spontaneous apoptosis of B-chroniclymphocytic leukemia lymphocytes. J BUON 2009;14(2):281-7.

6. Kuljic-Kapulica N, Stamatovic D, Savic D, Jovanovic D, Tukic Lj. and Andjelkovic N.Monitoring CMW infection after allogeneic stem cell transplantation. Vojnosanit Pregl inpress

7. Radovanović MR, Miletić GM, Radovanović MS. Uspešno lečenje polimedikamentnogtrovanja metoprololom, diltiazemom i cilazaprilom. Vojnosanit Pregl 2009; 66(11): 904-8.

8. Petrović M, Tomić I, Jovanović D. Faktori rizika za pojavu metastaza u mozgu kodlokalno odmaklog nemikrocelularnog karcinoma pluća nakon završene hemiozračneterapije. Vojnosanit Pregl 2009; 66 (11):876-80

9. Cekerevac I, Lazić Z, Novković Lj, Petrović M, Cupurdija V, Kitanović G, Todorović Z,Gajović O. Faktori koji utiču na tolerisanje napora i dispnoju kod bolesnika sahroničnom opstruktivnom bolešću pluća. Vojnosanit Pregl in press

10. Petrović M, Ilić N, Baskić D. Značaj neuroendokrinih markera u odgovoru na terapiju ipreživljavanje kod pacijenata sa odmaklim nemikrocelularnim karcinomom pluća. SrpArh Celok Lek in press

Page 15: ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte disturbances in a hospital. Pharmacoepidemiol Drug Saf 2009; 18(11):1026-33. IF 2.516 4. Jankovic

НУКЛЕАРНА МЕДИЦИНА1. Matovic DM, Jankovic MS, Jeremic M, Tasic Z, Vlajkovic M. Unexpected effect of

furosemide on radioiodine urinary excretion in patients with differentiatedthyroid carcinomas treated with Iodine 131. Thyroid 2009; 19(8):843-48. IF 3.000

2. Matović M, Janković S, Jeremić M, Novaković M, Milošev M, Vlajković M. Effectof furosemide on radioiodine-131 retention in mice thyroid gland. Hell J Nucl Med2009; 12(2):129-131.

Page 16: ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte disturbances in a hospital. Pharmacoepidemiol Drug Saf 2009; 18(11):1026-33. IF 2.516 4. Jankovic

ПАТОЛОШКА АНАТОМИЈА1. Zvrko E, Mikic A, Vuckovic Lj, Djukic V, Knezevic M. Prognostic relevance of

CD105-assessed microvessel density in laryngeal carcinoma. Otolaryngology-Head and Neck Surgery 2009; 141:478-83. IF 1.409

2. Bojanic V, Bojanic Z, Najman SJ, Savic T, Jakovljevic V, Najman SS, Jancic S.Diltiazem prevention of toxic effects of monosodium glutamate on ovaries in rats.General Physiology and Biophysics 2009; 28:149-54. IF 0.771

3. Joksimovic I, Bojanic V, Jancic S, Bojanic Z, Zivanov-Curlis J, Peric S, Jancic S.Precancerous morpholocic and functional aberration in the rat mammary glandscarcinogenesis. General Physiology and Biophysics 2009; 28:162-7. IF 0.771

4. Milosaljević MZ, Mitrović SLj, Vujadinović M, Aćimović Lj, Mrvić SA,Milisavljević SS. Giant dumbbell tumor of the posterior mediastinum.Vojnosanit Pregl 2009; 66(11):909-13.

5. Todorović M, Mitrović S, Aleksandrić B, Mladenović N, Matejić S. Pulmonaryhistopathological findings in forensic autopsies of illicit drugs users withtoxicological correlation. Vojnosanit Pregl in press

Page 17: ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte disturbances in a hospital. Pharmacoepidemiol Drug Saf 2009; 18(11):1026-33. IF 2.516 4. Jankovic

БИОХЕМИЈА

1. Stanojević M, Savin S, Cvejić D, Đukić A, Živančević-Simonović S. Correlationof thyroglobulin concentrations measured by radioimmunoassay andimmunometric assay and the influence of thyroglobulin antibody. J ImmunoassayImmunochem 2009, 30:197-207. IF 0.825

2. Stanojević M, Savin S, Cvejić D, Djukić A, Jeremić M. and Živancević-Simonović S. Comparison of the influence of thyroglobulin antibodies on serumthyroglobulin values from two different immunoassays in post surgicaldifferentiated thyroid carcinoma patients. Journal of Clinical Laboratory Analysis2009; 23(5):341-6 IF 0.696

3. Zelen I, Djurdjevic P, Popovic S, Stojanovic M, Jakovljevic V, Radivojevic S,Baskic D, Arsenijevic N. Antioxidant enzymes activities and plasma levels ofoxidative stress markers in B-chronic lymphocyte leukemia patients. J BUON inpress

4. Djurdjevic P, Zelen I, Ristic P, Jovanovic I, Jakovljevic V, Baskic D, Popovic S,Arsenijevic N. Oxidative stress accelerate spontaneous apoptosis of B-chroniclymphocytic leukemia lymphocytes. J BUON 2009;14(2):281-7.

Page 18: ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte disturbances in a hospital. Pharmacoepidemiol Drug Saf 2009; 18(11):1026-33. IF 2.516 4. Jankovic

ИНФЕКТИВНЕ БОЛЕСТИ

1. Bugracic ZD, Soldatovic T, Canovic P. Nikolic R, Jelic R. Equilibrium and 1HNMR kinetic study of the reactions of dichlorido [S-metihyl-L-cisteine (N,S)]platinum (II) complex with some relevant biomolecules. Journal of SolutionChemistry 2009; 38:57-71. IF 1.241

2. Cekerevac I, Lazić Z, Novković Lj, Petrović M, Cupurdija V, Kitanović G,Todorović Z, Gajović O. Faktori koji utiču na tolerisanje napora i dispnoju kodbolesnika sa hroničnom opstruktivnom bolešću pluća. Vojnosanit Pregl in press

Page 19: ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte disturbances in a hospital. Pharmacoepidemiol Drug Saf 2009; 18(11):1026-33. IF 2.516 4. Jankovic

ХИРУРГИЈА

1. Stojadinović MM, Mićić SR, Milovanović DR, Janković SM. Risk factorsfor treatment failure in renal suppurative infections. Int Urol Nephrol 2009;41(2): 319-25. IF 0.912

2. Ilić M, Stojadinović M, Milosavljević Z. Familial aggregation of bladdercancer-report of a case. Vojnosanit pregl in press

3. Milosaljević MZ, Mitrović SLj, Vujadinović M, Aćimović Lj, Mrvić SA,Milisavljević SS. Giant dumbbell tumor of the posterior mediastinum.Vojnosanit Pregl 2009; 66(11):909-13.

Page 20: ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte disturbances in a hospital. Pharmacoepidemiol Drug Saf 2009; 18(11):1026-33. IF 2.516 4. Jankovic

ПСИХИЈАТРИЈА

1. Ravanic DB, Djukic-Dejanovic SM, Janjic V, Jovic SD, Milovanovic DR,Jakovljevic V, Pantovic V, Ravanic B, Pantovic M. and Pantovic MM.Effectiveness of clozapine, haloperidol and chlorpromazine in schizofreniaduring a five-year period. Arquivos De Neuro-psiquiatria 2009; 67(2):195-202.IF 0.388

2. Ravanic DB, Pantovic MM, Milovanovic DR, Djukic-Dejanovic SM, JanjicV, Ignjatovic DR, Jovic SD, Jurisic V, Jevtovic I. Long-term efficacy ofelectroconvulsive therapy combined with different antipsichotic drugs inpreviously resistant shizophrenia. Psychiatr Danub 2009; 21(2): 179-86.

3. Miljkovic S, Djokic D, Djukic-Dejanovic S, Mitrasinovic D, Grbic G,Radosavljevic-Svetozarovic J, Krivokapic Z i Visnjic A. Obelezjareproduktivnog zdravlja zena u generativnom periodu. Srp Arhiv za CelokupLekarstvo in press

4. Miljkovic S, Djokic D, Djukic-Dejanovic S, Mitrasinovic D, Radosavljevic-Svetozarovic J Prelevic R, Krivokapic Z, Visnjic A. Cinioci koji odredjujunajznacajnije karakteristike reproduktivnog zdravlja. Srp Arhiv za CelokupLekarstvo in press

Page 21: ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte disturbances in a hospital. Pharmacoepidemiol Drug Saf 2009; 18(11):1026-33. IF 2.516 4. Jankovic

ГИНЕКОЛОГИЈА И АКУШЕРСТВО

1. Šorak M, Živanovic A, Varjačić M, Lukić G, Babić G. Ultrazvučnodijagnostikovana encefalocela kod fetusa u 13. nedelji gestacije. Vojnosanit Preglin press

2. Sedlar S, Jokic Z, Dimitrijevic A, Zivanovic A. Zbrinjavanje operativne rane namaterici posle laparaskopske mimektomije. Srp Arhiv za Celokup Lek in press

3. Đjorđević M, Vujić A, Jovanović B, Đjorđević G, Sazdanović M, Sazdanović P.Neonatal outcome exposed to organophosporous pesticides. Archives ofBiological Sciences in press

4. Đjorđević M, Jovanović B, Đjorđević G. Operativni tretman endometrioze uKliničkom Centru Kragujevac u periodu 2004-2008. godine. Med Glas in press

Page 22: ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte disturbances in a hospital. Pharmacoepidemiol Drug Saf 2009; 18(11):1026-33. IF 2.516 4. Jankovic

ХИСТОЛОГИЈА

1. Ilić M, Stojadinović M, Milosavljević Z. Familial aggregation of bladdercancer-report of a case. Vojnosanit pregl in press

2. Milosaljević MZ, Mitrović SLj, Vujadinović M, Aćimović Lj, Mrvić SA,Milisavljević SS. Giant dumbbell tumor of the posterior mediastinum.Vojnosanit Pregl 2009; 66(11):909-13.

3. Đjorđević M, Vujić A, Jovanović B, Đjorđević G, Sazdanović M, SazdanovićP. Neonatal outcome exposed to organophosporous pesticides. Archives ofBiological Sciences in press.

Page 23: ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte disturbances in a hospital. Pharmacoepidemiol Drug Saf 2009; 18(11):1026-33. IF 2.516 4. Jankovic

ЕПИДЕМИОЛОГИЈА

1. Ilic M, Markovic-Denic Lj. Prevalence study of nosocomial infections in oneuniversity hospital in Serbia. Vojnosanit Pregl in press

2. Ilić M, Stojadinović M, Milosavljević Z. Familial aggregation of bladdercancer-report of a case. Vojnosanit pregl in press

Page 24: ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte disturbances in a hospital. Pharmacoepidemiol Drug Saf 2009; 18(11):1026-33. IF 2.516 4. Jankovic

СОЦИЈАЛНА МЕДИЦИНА

1. Miljkovic S, Djokic D, Djukic-Dejanovic S, Mitrasinovic D, Grbic G,Radosavljevic-Svetozarovic J, Krivokapic Z i Visnjic A. Obelezjareproduktivnog zdravlja zena u generativnom periodu. Srp Arhiv zaCelokup Lekarstvo in press

2. Miljkovic S, Djokic D, Djukic-Dejanovic S, Mitrasinovic D, Radosavljevic-Svetozarovic J Prelevic R, Krivokapic Z, Visnjic A. Cinioci koji odredjujunajznacajnije karakteristike reproduktivnog zdravlja. Srp Arhiv za CelokupLekarstvo in press

Page 25: ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte disturbances in a hospital. Pharmacoepidemiol Drug Saf 2009; 18(11):1026-33. IF 2.516 4. Jankovic

ПЕДИЈАТРИЈА

1. Simović AM, Knežević J, Igrutinović Z, Stojanović N, Kocić S. Cardiac trponinas biochemical marker of perinatal asphyxia and hypoxic injury. VojnosanitPregl 2009; 66(11):881-6.

2. Radlović N, Mladenović M, Leković Z, Ristić D, Pavlović M, Stojšić Z, Vuletić B,Radlović V, Nikolić D, Djurdjević J, Gajić M. Lactose intolernace in infants withgluten sensitive enteropathy: frequency and clinical characteristics. Srp ArhCelok Lek 2009;137:(1-2): 33-7.

Page 26: ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte disturbances in a hospital. Pharmacoepidemiol Drug Saf 2009; 18(11):1026-33. IF 2.516 4. Jankovic

АНАТОМИЈА

1. Đjorđević M, Vujić A, Jovanović B, Đjorđević G, Sazdanović M, Sazdanović P.Neonatal outcome exposed to organophosporous pesticides. Archives ofBiological Sciences in press

Page 27: ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte disturbances in a hospital. Pharmacoepidemiol Drug Saf 2009; 18(11):1026-33. IF 2.516 4. Jankovic

ОРЛ

1. Zivic Lj, Ignjatovic S, Terzic N, Jakovljevic VLJ, Zivic D, Djonovic N. Uporednaanaliza audiometrijskih I impendcmetrijskih nalaza kod radnika izlozenih dejstvuindustrijske buke razlicitog vremenskog trajanja. Vojnosanit Pregl u stampi

Page 28: ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte disturbances in a hospital. Pharmacoepidemiol Drug Saf 2009; 18(11):1026-33. IF 2.516 4. Jankovic

СУДСКА МЕДИЦИНА

1. Todorović M, Mitrović S, Aleksandrić B, Mladenović N, Matejić S. Pulmonaryhistopathological findings in forensic autopsies of illicit drugs users withtoxicological correlation. Vojnosanit Pregl in press

Page 29: ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte disturbances in a hospital. Pharmacoepidemiol Drug Saf 2009; 18(11):1026-33. IF 2.516 4. Jankovic

Радови објављени у осталим научним часописима

Page 30: ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte disturbances in a hospital. Pharmacoepidemiol Drug Saf 2009; 18(11):1026-33. IF 2.516 4. Jankovic

1. Volarevic V, Arsenijevic N, Lukic M. Interleukin 1 Receptor Antagonist and(IL-1Ra) IL-Ra Producing Mesenchymal Stem Cell in Therapy of DiabetesMellitus. Journal of Medical Sciences 2009; 2(2): 52-60.

2. Matovic DM, Jankovic MS, Jeremic M, Tasic Z, Vlajkovic M. Whole-bodyradioiodine retention 72 hours after 131I therapy is paradoxically higher inpatients treated with furosemide and potassium chloride than in a controlgroup. Clinical Thyroidology 2009; 21(8):11-13

3. Ilic KV, Sefik-Bukilica M, Jankovic S, Vujasinovic-Stupar N. Efficacy and safetyof two generic copies of nimesulide in patients with low back pain or kneeosteoarthritis. Reumatismo 2009;61(1):27-33.

4. Djurić D, Stanulović M. Delotvornost biotehnološki proizvedenog epoetinazeta (Eqralys), u lečenju anemije usled hronične bubrežne bolesti. Ser J Exp ClinRes 2008; 31:9-13.

5. Petrović D, Jagić N, Miloradović V, Stojimirović B. Nontradicional risk factorsfor development of cardiovascular complications in hemodialysis patients. Ser JExp Clin Res 2009; 10(3): 95-102.

6. Folić MM, Janković SM, Folić MD, Varjačić MR. Costs of caesarean sectionand vaginal delyveri in an upper-middle-income country: a case series. Ser JExp Clin Res 2009; 10(2):61-4.

7. Jevtić T, Zeqiri M, Vukomanović J, Milovanović D, Jevtić M. Aplication ofmethylprednisolone suspension by iontophoresis in patients with arthrosis ofthe knee. Ser J Exp Clin Res 2009; 9(1): 13-7.

8. Pantovic M, Milovanovic S, Milovanovic D, Pantovic V, Matovic M, Ravanic B,Pantovic M, Ravanic D. Cornerstones of Serbian medicine: dr Vladimir Vujic.Ser J Exp Clin Res 2009; 10(1): 5-9.

9. Krkeljic J, Cubrilo D, Zivkovic V, Vuletic M, Barudzic N, Jakovljevic VLj. Theeffects of different doses of vardenafil on coronary auto-regulation in isolatedrat heart. Ser J Exp Clin Res 2009; 10(3): 103-8.

Page 31: ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte disturbances in a hospital. Pharmacoepidemiol Drug Saf 2009; 18(11):1026-33. IF 2.516 4. Jankovic

10. Mitrovic S, Stankovic V, Milisavljevic S, Mrvic S, Milosavljevic M. Cervicalsympathetic chain schvannoma. Ser J Exp Clin Res 2009; 10(2):69-72.

11. Zvrko E, Mikic A, Vuckovic Lj, Knezevic M, Djukic V. The study of E-cadherinexpression in glottic laryingeal squamosus cell carcinoma. Serb J Exp and Clin Res2009; 10(3):89-94.

12. Medjedović S, Jakovljević V, Vujanić S, Pavlović M, Ranđelović D, Komadina-Vuković M. Significance of NT-PRO-BNP in evaluation of left venticular function inpatients with acute coronary syndrome. Serb J Exp and Clin Res 2009; 10(1):9-13.

13. Parezanović-Ilić K, Jevtić M, Arsenijević S, Jeremić B. The assessment of kinesis-therapeutic treatment using numerical evaluation of pelvic floor muscle forces. Serb JExp and Clin Res 2009; 10(1):23-6.

14. Stankovic V, Tanaskovic I, Knezevic M, Kastratovic T, Mitrovic S. Correlation ofp53 expression levels and colorectal carcinomas location. Serb J Exp and Clin Res2009; 10(2): 53-9.

15. Milovanović S, Djurić D, Voskresenski T, Djurić I. Depresije – faktor rizika za njihovnastanak kod žena. Serb J Exp and Clin Res 2009; 35:18-23.

16. Drazic B, Popovic G, Jelic R, Sladic D, Mitic D, Andjelkovic K, Tesic Z, Acid-baseequilibria of the Zn(II) and Fe(III) complexes with condensation products of 2-acetylpyridine and the dihydrazide of oxalic and malonic acid. Journal of the SerbianChemical Society 2009; 74(3):269-77.

17. Đukić A, Živančević-Simonović S, Varjačić M. and Đukić S. Hiperlipidemija itrudnoća. Med Pregl 2009; LXII (3):80-4.

18. Obradović S, Laban O, Igrutinović Z, Vuletić B, Vujic A, Đinđić J. GangliozidozaGmi-prikaz slučaja. Medicinski pregled in press

19. Djonovic N, Milic C, Kocic S, Radovanovic S. Skolioza kod dece od 7 do 18 godina iuslovi rada u osnovnim i srednjim skolama na teritoriji grada Kragujevca. Med Preglu stampi

20. Terzic N, Jakovljevic V, Milanovic N, Jacimovic V, Zivic LJ. Stanje sluha I tinitusapre i posle lecenja otoskleroze. Medicin Pregl u stampi

21. Radovanović S, Kocić S, Šorak M, Milić Č. Stavovi i ponašanja studenata u vezi sareproduktivnim zdravljem. Medicinski pregled u štampi

Page 32: ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte disturbances in a hospital. Pharmacoepidemiol Drug Saf 2009; 18(11):1026-33. IF 2.516 4. Jankovic

22. Radovanović S, Milić Č, Kocić S. Opšte karakteristike upotrebe i zloupotrebepsihoaktivnih supstanci kod srednjoškolske omladine. Medicinski pregled u štampi

23. Milić Č. Sezonske varijacije-faktor rizika za nastanak suicida. Medicinski pregled uštampi

24. Folic M, Folic N, Varjacic M, Jakovljevic M. Jankovic S. Antihypertensive drugtherapy for hypertensive disorders in pregnancy. Acta Medica Medianae 2008;47(3):65-72.

25. Jakovljevic M, Biorac N, Markovic V. Uloga komplijanse pacijenata u terapijihroničnih oboljenja-farmakoekonomska perspektiva. Medicinski casopis 2008;42(1):57-63.

26. Petrović D, Nikolić A, Stojimirović B. Poremećaj metabolizma lipida u hroničnojslabosti bubrega: klinički značaj i lečenje. Medicinski Časopis 2009; 43(1): 21-7.

27. Radovanović S. Milić Č. Kocić S, Đonović N. Učestalost i rasprostranjenostmalignih neoplazmi. Zdravstvena zaštita 2009; 2: 3

28. Popović P, Milić Č, Kocić S, Radovanović S. Vanbolnički morbiditet stanovništvagrada Kragujevca. Zdravstvena zaštita 2009; 1:29-35.

29. Milovanović JR. Praćenje lekova u terapiji. Racionalna terapija 2009; 1: 11-12.30. Janković S. Racionalna primena antibiotika u kliničkoj praksi. Racionalna terapija

2009; 1: 1-6.31. Janković S. Racionalna upotreba benzodiazepina. Racionalna terapija 2009; 1: 7-10.32. Stefanović S, Janković S, Ružić-Zečević D, Mladenović V. Akutna bubrežna

insuficijencija izazvana jodnim kontrastnim sredstvom: prikaz slučaja. Racionalnaterapija 2009;1(1):15-20.

33. Potpara Z, Cupara S, Marstijepović N, Bojović D. Medicinski peloid. Racionalnaterapija 2009; 1(2):25-30.

Page 33: ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte disturbances in a hospital. Pharmacoepidemiol Drug Saf 2009; 18(11):1026-33. IF 2.516 4. Jankovic

МОНОГРАФИЈЕ

Page 34: ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte disturbances in a hospital. Pharmacoepidemiol Drug Saf 2009; 18(11):1026-33. IF 2.516 4. Jankovic

1. Janković S, ur. Dobra praksa u radu etičkih odbora. Medicinski fakultetKragujevac; 2009

2. Janković S. Priručnik iz farmakologije i toksikologije. 3. izd. Medicinskifakultet Kragujevac; 2009

3. Milovanović D. Obaveze glavnog istraživača kliničke studije. U: Janković S,ur. Dobra praksa u radu etičkih odbora. Medicinski fakultet Kragujevac,2009: 91-7.

4. Milovanović D. Genetska ispitivanja u kliničkim studijama. U: Janković S,ur. Dobra praksa u radu etičkih odbora. Kragujevac: Medicinski fakultet,2009: 115-9.

5. Milovanović JR. Antiepileptici i populaciona farmakokinetika. Beograd:Zadužbina Andrejević; 2009

6. Novokmet S, Janković S, urednici. Laboratorijske vežbe iz farmacije ifarmakologije III. Kragujevac: Odsek za farmaciju, Medicinski fakultet,Univerzitet u Kragujevcu, 2009.

7. Poskurica M. Akutna bubrežna insuficijencija: preventiva, dijagnostika,lečenje. Medicinski fakultet Kragujevac, Inter print Kragujevac, Kragujevac2009.

8. Poskurica M. Kardio-renalni sindrom: definicija, etiopatogeneza, kliničkaslika, dijagnostika, preventiva i lečenje. U: Akutna bubrežna insuficijencija:preventiva, dijagnostika i lečenje. Poskurica M. Ed.: 77-102. Medicinskifakultet Kragujevac 2009.

Page 35: ПУБЛИКОВАЛИ СМО smo 2009.pdf · Monitoring of drug- associated electrolyte disturbances in a hospital. Pharmacoepidemiol Drug Saf 2009; 18(11):1026-33. IF 2.516 4. Jankovic

9. Petrović D. Osnovi anatomije i fiziologije bubrega. U: Akutna bubrežnainsuficijencija: preventiva, dijagnostika i lečenje. Poskurica M. Ed.: p11-22.Medicinski fakultet Kragujevac 2009.

10. Stojimirović B, Trbojević-Stanković J, Petrović D. Akutna tubulska nekroza:definicija, etiologija, klinička slika, dijagnostika, preventiva i lečenje. U:Akutna bubrežna insuficijencija: preventiva, dijagnostika i lečenje. PoskuricaM. Ed.: p35-48. Medicinski fakultet Kragujevac 2009.

11. Petrović D, Lazarević T, Poskurica M. Rabdomioliza: etiologija, dijagnostika ilečenje. U: Akutna bubrežna insuficijencija: preventiva, dijagnostika i lečenje.Poskurica M. Ed.: p49-57. Medicinski fakultet Kragujevac 2009.

12. Petrović D, Jagić N, Miloradović V, Poskurica M. Kontrastna nefropatija:definicija, patogeneza, dijagnostika, preventiva i lečenje. U: Akutna bubrežnainsuficijencija: preventiva, dijagnostika i lečenje. Poskurica M. Ed.: p59-76.Medicinski fakultet Kragujevac 2009.

13. Petrović D, Stojimirović B. Lupus nefritis: dijagnostika i lečenje. U: Akutnabubrežna insuficijencija: preventiva, dijagnostika i lečenje. Poskurica M. Ed.:p121-36. Medicinski fakultet Kragujevac 2009.

14. Petrović D, Novaković B, Jagić N, Poskurica M, Stojimirović B. Kliničkiznačaj kolor dopler ultrasonografije u dijagnostikovanju renovaskularnehipertenzije. U: Kardionefrologija 4. Radenković S. Ed.: p188-93. GIP“PUNTA“, Niš 2009.

15. Petrović D, Poskurica M, Stojimirović B. Poremećaj dijastolne funkcije srcakod bolesnika koji se leče hemodijalizom: dijagnostika i lečenje. U:Kardionefrologija 4. Radenković S. Ed.: 213-20. GIP “PUNTA“, Niš 2009.

16. Stefanović S, Janković S. Izrada standardne procedure rada Etičkog odbora.U: Janković S, ur. Dobra praksa u radu Etičkih odbora. p83-90. Medicinskifakultet u Kragujevcu; 2009

17. Pavlica Lj, Prostran M, Nikolić D, Đurić D, Divac N, Stojanović R, Vučković S,Janković S, Todorović Z, Nešić Z. Dijagnoza i terapija Reaktivnog Artritisa.Centar millennium AD, Vršac 2008.